Sort   by:  
 Page size 
UnknownCirculating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.
Not available
S-EPMC10809477 | biostudies-literature
UnknownComparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.
Not available
S-EPMC9054878 | biostudies-literature
UnknownLong-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7616743 | biostudies-literature
UnknownEffects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease.
Not available
S-EPMC10907814 | biostudies-literature
UnknownFactors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers.
Not available
S-EPMC9135702 | biostudies-literature
UnknownEmpagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7614055 | biostudies-literature
UnknownEndogenously Expressed Antigens Bind Mammalian RNA via Cationic Domains that Enhance Priming of Effector CD8 T Cells by DNA Vaccination.
Not available
S-EPMC6403493 | biostudies-literature
UnknownHospitalizations in patients with idiopathic pulmonary fibrosis.
Not available
S-EPMC8481759 | biostudies-literature
UnknownFrailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031 | biostudies-literature
UnknownAssociations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.
Not available
S-EPMC8740873 | biostudies-literature
Sort   by:  
 Page size